Cargando…
The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
Patients with bloodstream infections (BSI) are associated with high mortality rates. Due to tigecycline has shown excellent in vitro activity against most pathogens, tigecycline is selected as one of the candidate drugs for the treatment of multidrug-resistant organisms infections. The purpose of th...
Autores principales: | Wang, Jian, Pan, Yaping, Shen, Jilu, Xu, Yuanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382384/ https://www.ncbi.nlm.nih.gov/pubmed/28381268 http://dx.doi.org/10.1186/s12941-017-0199-8 |
Ejemplares similares
-
The Characteristics of Extended-Spectrum β-Lactamases (ESBLs)-Producing Escherichia coli in Bloodstream Infection
por: Li, Rongrong, et al.
Publicado: (2023) -
Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis
por: Zha, Lei, et al.
Publicado: (2020) -
Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review
por: Liu, Yang-Xi, et al.
Publicado: (2021) -
Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis
por: Gong, Jinhong, et al.
Publicado: (2019) -
Bloodstream infection with pandrug-resistant Alcaligenes faecalis treated with double-dose of tigecycline
por: Hasan, Md Jahidul, et al.
Publicado: (2019)